Protalix BioTherapeutics (PLX) Non-cash Items (2017 - 2025)

Protalix BioTherapeutics' Non-cash Items history runs 9 years deep, the most recent figure standing at $5.5 million for Q4 2025.

• In Q4 2025, Non-cash Items rose 28.65% year-over-year to $5.5 million; the TTM figure through Dec 2025 stood at $5.5 million (up 28.65% YoY), while the FY2025 annual figure was $5.5 million, up 28.65% from the prior year.
• Non-cash Items was $5.5 million for Q4 2025 at Protalix BioTherapeutics, up from $4.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $5.5 million in Q4 2025 to a low of $192500.0 in Q4 2021.
• Historically, Non-cash Items has averaged $2.7 million across 5 years, with a median of $2.6 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Non-cash Items jumped 523.38% in 2022, then gained 28.65% in 2025.
• A 5-year view of Non-cash Items shows it stood at $192500.0 in 2021, then surged by 523.38% to $1.2 million in 2022, then jumped by 116.67% to $2.6 million in 2023, then soared by 63.38% to $4.2 million in 2024, then increased by 28.65% to $5.5 million in 2025.
• The last three Non-cash Items figures came in at $5.5 million (Q4 2025), $4.2 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.